Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: Pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement

Seminars in Diagnostic Pathology

Volumn 29, Issue 3, 2012, Pages 127-141

  Adsay, N Volkan ^a   Bagci, Pelin ^b   Tajiri, Takuma ^c   Oliva, Irma ^a   Ohike, Nobuyuki ^c   Balci, Serdar ^a   Gonzalez, Raul S ^a   Basturk, Olca ^d   Jang, Kee Taek ^e   Roa, Juan Carlos ^f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (Turkey)

^c SHOWA UNIVERSITY   (Japan)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Ampulla; Bile duct; Gallbladder; Lymph node; Pancreas; Stage

Indexed keywords

ARTICLE; BILE DUCT CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CLINICAL PRACTICE; GALLBLADDER CANCER; GASTRINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MUCINOUS CYSTIC NEOPLASM; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PANCREATITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME;

AMPULLA OF VATER; BILIARY TRACT NEOPLASMS; COMMON BILE DUCT NEOPLASMS; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 84867475755     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.08.010     Document Type: Article

References (63)

1. Roberts N.J., Jiao Y., Yu J., et al. ATM Mutations in Patients with Hereditary Pancreatic Cancer. Cancer Discovery 2012, 2:41-46.
2. Surveillence Epidemiology and End Results (SEER). Cancer Statistics NCI. http://seer.cancer.gov/statfacts/html/pancreas.html.
3. Andia K.M., Gederlini G.A., Ferreccio R.C. Cáncer de vesícula biliar: Tendencia y distribución del riesgo en Chile. Revista médica de Chile 2006, 134:565-574.
4. Mazer L., Losada H., Chaudhry R., et al. Tumor Characteristics and Survival Analysis of Incidental Versus Suspected Gallbladder Carcinoma. Journal of Gastrointestinal Surgery 2012, 16(7):1311-1317.
5. AJCC Cancer Staging Manual 2010, 238. Springer-Verlag, New York. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
6. Adsay N.V., Klimstra D.S. Pancreatic Tumors and Pancreatic Resection. Pathology and Classification of Pancreatic and Ampullary Tumors. Surgery of the Liver, Biliary Tract and Pancreas 2007, Vol. 1. Elsevier, Philadelphia. 4th ed. L.H. Blumgart (Ed.).
7. Adsay N.V., Klimstra D.S. Benign and Malignant Tumors of the Gallbladder and Extrahepatic Biliary Tract. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreas 2009, Vol. 1:845-875. Elsevier, Philadelphia. 4 ed. R.D. Odze, J.R. Goldblum (Eds.).
8. Parkash V., Domfeh A., Cohen P., Fadare O. Re: "Behjatnia B et al. "Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens". Int J Clin Exp Pathol 2010;3(3):303-309". International journal of clinical and experimental pathology 2010, 3(4):458-460.
9. Tanaka M., Fernandez-Del Castillo C., Adsay V., et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012, 12(3):183-197.
10. Jang K.T., Dursun N., Basturk O., et al. Invasive carcinomas arising from pancreatic mucinous cystic neoplasms (MCNs) with ovarian stroma: a clinicopathologic analysis of 25 cases with invasive carcinoma identified in 131 MCNs. Modern Pathology 2011, 24(1):363A.
11. Oliva I., Bandyopadhyay S., Coban I., et al. Peripancreatic soft tissue involvement by pancreatic ductal adenocarcinomas: incidence, patterns and significance. Mod Pathol 2009, 22(1):318A.
12. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000, 4(6):567-579.
13. Adsay N.V., Basturk O., Altinel D., et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 2009, 22(1):107-112.
14. Washington K., Berlin J., Branton P., et al. Protocol for the Examination of Specimens from Patients with Carcinoma of the Exocrine Pancreas http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/PancreasExo_11protocol.pdf.
15. Hruban R.H., Pitman M.B., Klimstra D.S. Tumors of the Pancreas 2007, Vol 1. ARP Press, Washington, DC, Fascicle 6. 4 ed.
16. Oliva I., Bandyopadhyay S., Coban I., et al. Incidence and significance of common bile duct involvement in resected pancreatic ductal adenocarcinomas: should it be represented in the TNM staging?. Mod Pathol 2009, 22(1):319A.
17. Klimstra D.S., Modlin I.R., Adsay N.V., et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010, 34(3):300-313.
18. Klöppel G., Rindi G., Perren A., Komminoth P., Klimstra D. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Archiv 2010, 456(6):595-597.
19. Estrella J.S., Broaddus R., Yao J.C., Wang H., Rashid A. Combined progesterone receptor and PTEN expression predicts metastasis and survival in patients with pancreatic neuroendocrine tumors. Modern Pathology 2012, 25:442A.
20. Rindi G., Falconi M., Klersy C., et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. Journal of the National Cancer Institute 2012, 104(10):764-777.
21. Schwarz R., Smith D. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Annals of Surgical Oncology 2006, 13(9):1189-1200.
22. Bilimoria K.Y., Talamonti M.S., Wayne J.D., et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 2008, 143(7):671-678.
23. Pawlik T.M., Gleisner A.L., Cameron J.L., et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007, 141(5):610-618.
24. Sierzega M., Popiela T., Kulig J., Nowak K. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 2006, 33(3):240-245.
25. Partelli S., Fernandez-Del Castillo C., Bassi C., et al. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio. Ann Surg 2010, 251(3):477-482.
26. Pai R.K., Beck A.H., Mitchem J., et al. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease. Am J Surg Pathol 2011, 35(2):228-234.
27. Negi S.S., Singh A., Chaudhary A. Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio?. J Gastrointest Surg 2011, 15(6):1017-1025.
28. Marchet A., Mocellin S., Ambrosi A., et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 2008, 34(2):159-165.
29. Marchet A., Mocellin S., Ambrosi A., et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007, 245(4):543-552.
30. Megale Costa L.J., Soares H.P., Gaspar H.A. Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 2004, 27:304-306.
31. Mocellin S., Pasquali S., Rossi C.R., Nitti D. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. Surgery 2011, 150(1):83-90.
32. Konstantinidis I.T., Deshpande V., Zheng H., et al. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?. J Gastrointest Surg 2010, 14(2):261-267.
33. Anlauf M., Enosawa T., Henopp T., et al. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol 2008, 32(7):1101-1105.
34. Washington K., Berlin J., Branton P., et al. Protocol for the examination of specimens from patients with carcinoma of the ampulla of vater http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Ampulla_11protocol.pdf.
35. Albores-Saavedra J., Henson D.E., Klimstra D.S. Malignant Epithelial Tumors of the Ampulla. Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater. Atlas of Tumor Pathology 2000, Vol. 1:259-316. Armed Forces Institute of Pathology, Washington DC. 3 ed. H. Rosai (Ed.).
36. Cubilla A.L., Fitzgerald P.J. Surgical pathology aspects of the ampulla-head of pancreas region. Monogr Pathol 1980, 21:67-81.
37. Tasaka K. Carcinoma in the region of the duodenal papilla. A histopathologic study (author's transl). Fukuoka Igaku Zasshi 1977, 68(1):20-44.
38. Tajiri T., Tate G., Kunimura T., et al. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas 2004, 29:116-122.
39. TNM Frequently Asked Questions UICC. http://www.uicc.org/resources/tnm-frequently-asked-questions.
40. Adsay V.N., Ohike N., Tajiri T., et al. Reappraisal of the definition and site specific classification of ampullary carcinomas: delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol (epub ahead of print) 2012.
41. Gonzalez R.S., Bagci P., Kong S.Y., et al. Distal common bile duct adenocarcinomas: analysis of 47 cases and comparison with pancreatic and ampullary ductal carcinomas (abstract). Mod Pathol 2012, 25(2):109A.
42. Ohike N., Kim G.E., Tajiri T., et al. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Am J Surg Pathol 2010, 34(12):1731-1748.
43. Tajiri T., Ohike N., Balci S., et al. Proposal for a more applicable and clinically relevant staging evaluation of ampullary carcinomas. Modern Pathology 2011, 24:169.
44. Puppa G., Sonzogni A., Colombari R., Pelosi G. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Archives of Pathology & Laboratory Medicine 2010, 134(6):837-852.
45. Panarelli N., Brandt S.M., Yantiss R.K. Serosal scraping of cancer specimens aids the detection of serosal penetration by invasive carcinoma (abstract). Mod Pathol 2011, 24(Supp):162A.
46. Hong S.-M., Pawlik T.M., Cho H., et al. Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 2009, 146(2):250-257.
47. Hong S.M., Cho H., Moskaluk C.A., Yu E. Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 2007, 31(2):199-206.
48. Sanzana N.D., Álamos J.C.G., Salazar A.M.J., et al. Primer informe de registiros poblacionales de cancer de chile quinquenio 2003-2007 http://www.vent.cl/wp-content/uploads/2012/04/INFORME%20RPC%20CHILE%202003-2007,%20UNIDAD%20VENT,%20DEPTO.EPIDEMIOLOGIA-MINSAL,13.04.2012(2).pdf.
49. Roa I., Araya J.C., de Aretxabala X., Salinas C., Wistuba I. [Gallbladder pathology in temuco, IX region]. Rev Med Chil 1989, 117(8):889-894.
50. Roa I. Proposición de procesamiento de biopsias de la vesícula biliar, clasificación y etapificación el cáncer de la vesícula biliar. Rev Chil Cirugia 2005, 57(5):436-442.
51. Frierson H.F. The gross anatomy and histology of the gallbladder, extrahepatic bile ducts, Vaterian system, and minor papilla. Am J Surg Pathol 1989, 13(2):146-162.
52. Roa I., Araya J.C., Villaseca M., et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology 1996, 111(1):232-236.
53. de Aretxabala X., Roa I., Hepp J., et al. Early gallbladder cancer: is further treatment necessary?. Journal of Surgical Oncology 2009, 100(7):589-593.
54. de Aretxabala X., Roa I., Burgos L. Gallbladder cancer, management of early tumors. Hepato-gastroenterology 1999, 46(27):1547-1551.
55. Barreto S.G., Shukla P.J. Defining the completeness of surgery for early gallbladder cancer. Ann Surg 2008, 248(5):896-897.
56. Downing S.R., Cadogan K.-A., Ortega G., et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results Database effect of extended surgical resection early-stage gallbladder cancer. Archives of Surgery 2011, 146(6):734-738.
57. Roa J.C.S., Tapia O.E., Manterola C., et al. Rokitansky aschoff sinus Involvement in early gallbladder carcinoma (EGBC) as a prognostic factor: a concurrent cohort study of 190 EGBC. Modern Pathology 2011, 24(1):373A.
58. Adsay V., Jang K.T., Carlos J.C., et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are >1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 2012, 36(9):1279-1301.
59. Adsay N.V., Klöppel G., Fukushima N., et al. Intraductal neoplasms of the pancreas. WHO Classification of Tumours of the Digestive System 2010, Vol. 1:304-313. IARC, Lyon. 4 ed. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).
60. Klimstra D.S., Adsay N.V., Dhall D., et al. Intraductal tubular carcinoma of the pancreas: clinicopathologic and immunohistochemical analysis of 18 cases. Mod Pathol 2007, 20(2):285A.
61. Adsay N.V., Pierson C., Sarkar F., et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001, 25(1):26-42.
62. Nara S., Shimada K., Kosuge T., et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2008, 32(2):243-255.
63. Albores-Saavedra J., Murakata L., Krueger J.E., Henson D.E. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 2000, 89(3):508-515.